CytomX Therapeutics CTMX
NASDAQ CTMX
$2.40 -0.11 (-4.38%)
At close: Oct 21, 2026 · 4:00 PM EDT

CytomX Therapeutics (CTMX) Deferred Taxes (2015 - 2017)

Updated

CytomX Therapeutics' Deferred Taxes came in at -$520,000 for Q4 2017.

Analysis

CytomX Therapeutics (CTMX) Deferred Taxes (2015 - 2017) Analysis & Trends

For FY2017, CytomX Therapeutics' Deferred Taxes was -$513,000.

  • Going back by year, Deferred Taxes was $6,000 in FY2016 (-25.0%), $8,000 in FY2015 (unchanged), $8,000 in FY2014 (-20.0%) and $10,000 in FY2013.
  • Business Quant data shows CTMX's Deferred Taxes at -$19,000 (Q3 2017), $25,000 (Q2 2017) and $1,000 (Q1 2017) in the three quarters before Q4 2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Deferred Taxes (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 1.05 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -479.00 Mn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -195.00 Mn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -544.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -291.00 Mn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -587.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -1.32 Bn
10 CytomX Therapeutics 526.55 Mn -431.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2017 -520,000.00
Sep 30, 2017 -19,000.00
Jun 30, 2017 25,000.00
Mar 31, 2017 1,000.00
Jun 30, 2016 3,000.00
Mar 31, 2016 3,000.00
Sep 30, 2015 3,000.00
API Access

CytomX Therapeutics Deferred Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=deferred-taxes&ticker=CTMX&period=max&api_key=YOUR_API_KEY